ENB Therapeutics’ Orphan Drug, Endothelin Receptor Type B Target for Resistant Cancers February 15, 2023
2 Women-Founded Companies are Optimizing Targeted Lipid Nanoparticle mRNA Therapies for a Rare Respiratory DiseaseFebruary 3, 2023
culture Yoko Shimizu: Around the World and Back – to New YorkBy Veta ObazenuOctober 16, 2022“THE FUSION OF ART AND SCIENCE OPENS DOORS TO POSSIBILITIES BEYOND OUR IMAGINATION”- Yoko Shimizu As artists visualize abstract concepts… Read More
